Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ABBV-969 |
Synonyms | |
Therapy Description |
Limited information is currently available on ABBV-969, a putative antibody-drug conjugate (ADC) targeting PSMA and STEAP1 (Mar 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ABBV-969 | ABBV 969|ABBV969 | PSMA Antibody 20 | Limited information is currently available on ABBV-969, a putative antibody-drug conjugate (ADC) targeting PSMA and STEAP1 (Mar 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06318273 | Phase I | ABBV-969 | A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer | Recruiting | USA | ISR | AUS | 1 |